New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

Conference call to provide business updates today, February 25 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 25 ...

Feb 12 (Reuters) - Eli Lilly (LLY.N), opens new tab had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision ...

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug Administration (FDA) recently approved a daily pill form of Wegovy, making it the ...

Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China. Kailera Therapeutics and Hengrui Pharma have claimed mid-stage victory for ...

On Friday, the U.S. Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 ingredients in compounded drugs not approved by the agency. Last week, Hims & Hers announced ...

Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move escalates the ...

View post: Trader Joe's Recalls 4 Frozen Foods That May Contain Glass. Here's What You Need to Know. Hims announced, then quickly retracted, a compounded semaglutide pill for weight loss. FDA cracked ...

Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal regulators vowed to take action against the telehealth provider. “Since ...